Available IPD datapackage for study 'A Phase 3, Randomized, Double Blind, Placebo and Tamsulosin Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil Once a Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia'

This study is a randomized, double-blind, placebo and tamsulosin-controlled, parallel design, multinational study to evaluate the efficacy and safety of Tadalafil once-a-day dosing for 12 weeks in Asian men with signs and symptoms of benign prostatic hyperplasia (BPH).

本研究为一项随机、双盲、以安慰剂与坦索罗辛（Tamsulosin）为对照的平行设计多国临床试验，旨在评估每日一次给药的他达拉非（Tadalafil）方案，对伴有良性前列腺增生（BPH）体征与症状的亚洲男性实施为期12周治疗的有效性与安全性。